高级检索
当前位置: 首页 > 详情页

The role of CNPY2 in endothelial injury and inflammation during the progress of atherosclerosis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Peoples R China [2]Kunming Univ Sci & Technol,Affiliated Hosp,Peoples Hosp Yunnan Prov 1,Dept Geriatr Med,Kunming 650032,Peoples R China [3]First Peoples Hosp Yunnan Prov,Dept Neurol,Kunming 650032,Peoples R China [4]First Peoples Hosp Yunnan Prov,157 Jinbi Rd,Kunming 650032,Yunnan,Peoples R China
出处:
ISSN:

关键词: Atherosclerosis Vascular endothelial cells Endoplasmic reticulum stress Inflammation and apoptosis

摘要:
Vascular endothelial cells (VECs) injury is closely related to the occurrence and development of atherosclerosis. Canopy FGF signaling regulator 2 (CNPY2), a novel unfolded protein response promoter, has been reported to activate the PERK-CHOP pathway. This study aimed to explore whether CNPY2 is associated with atherosclerosis mediated by VEC injury. By establishing ApoE(-/-) mouse atherosclerosis model and oxidized low-density lipoprotein (ox-LDL) cell model, we found that CNPY2 was abnormally highly expressed in ApoE(-/-) mice and ox-LDL-induced mouse aortic endothelial cells (MAECs). Exogenous CNPY2 can significantly aggravate the activation, inflammation, and apoptosis of MAECs induced by ox-LDL and promote the activation of PERK/eIF2 alpha/CHOP signal. The PERK inhibitor GSK2606414 can inhibit CNPY2-induced MAECs injury and PERK signal activation. In addition, in vivo animal experiments furtherly confirmed that CNPY2 could aggravate the process of atherosclerosis in ApoE(-/-) mice by activating PERK signaling. In conclusion, this study indicated that high level of CNPY2 induces VECs injury by activating PERK signaling and thus participating in the progress of atherosclerosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学
最新[2023]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学
JCR分区:
出版当年[2022]版:
Q3 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Peoples R China [2]Kunming Univ Sci & Technol,Affiliated Hosp,Peoples Hosp Yunnan Prov 1,Dept Geriatr Med,Kunming 650032,Peoples R China
通讯作者:
通讯机构: [3]First Peoples Hosp Yunnan Prov,Dept Neurol,Kunming 650032,Peoples R China [4]First Peoples Hosp Yunnan Prov,157 Jinbi Rd,Kunming 650032,Yunnan,Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82183 今日访问量:0 总访问量:679 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号